Variables | Control group | PostC group | p |
---|---|---|---|
n = 35 | n = 33 | ||
At admission | |||
Age, years (range) | 62 (42–85) | 63 (37–85) | 0.96 |
Male sex | 31 (89) | 28 (85) | 0.73 |
Body mass index, kg/m2 (IQR) | 27 (25, 29) | 27 (25, 31) | 0.37 |
Ischemia time, minutes (IQR) | 180 (141, 255) | 165 (133, 202) | 0.27 |
Current smokers | 9 (26) | 9 (27) | 1.0 |
Hypertension | 11(31) | 5(15) | 0.16 |
Previous angina | 3 (9) | 5 (15) | 0.47 |
Diabetes mellitus* | 10 (32) | 9 (29) | 1.0 |
Treatment on admission | |||
Aspirin, | 3 (9) | 1 (3) | 0.61 |
Beta-blockers | 4 (11) | 1 (3) | 0.36 |
ACE/ARB | 6 (17) | 2 (6) | 0.26 |
Statins | 3 (9) | 2 (6) | 1.0 |
Treatment during angioplasty | |||
Aspirin | 35 (100) | 31 (94) | 0.23 |
Clopidogrel | 34 (97) | 31 (94) | 0.61 |
Glycoprotein inhibitors | 27 (77) | 26 (79) | 1.0 |
Opioids | 26 (74) | 28 (85) | 0.37 |
Treatment at discharge | |||
Aspirin, n (%) | 35 (100) | 32 (97) | 0.49 |
Clopidogrel, n (%) | 35 (100) | 33 (100) | 1.0 |
Beta-blockers, n (%) | 34 (97) | 33 (100) | 1.0 |
ACE/ARB, n (%) | 20 (57) | 21 (61) | 0.64 |
Statins, n (%) | 34 (97) | 32 (97) | 1.0 |